Corporate News     14-Nov-22
Alembic Pharmaceuticals receives USFDA approval for Cyclophosphamide Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide Capsules, 25 mg and 50 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Cyclophosphamide Capsules, 25 mg and 50 mg, of Hikma Pharmaceuticals USA Inc.

Cyclophosphamide Capsules is an alkylating drug indicated for the treatment of malignant disease and minimal change nephrotic syndrome in pediatric patients.

Cyclophosphamide Capsules, 25 mg and 50 mg, have an estimated market size of US$ 8 million for twelve months ending Sep 2022 according to IQVIA.

Previous News
  Alembic Pharma reports turnaround Q1 numbers
 ( Hot Pursuit - 05-Aug-23   12:56 )
  Alembic Pharma gains on USFDA nod for Mesalamine capsules
 ( Hot Pursuit - 02-Nov-22   12:28 )
  Alembic Pharma gets USFDA final approval for Prazosin Hydrochloride capsules
 ( Hot Pursuit - 08-Mar-23   09:19 )
  Alembic Pharmaceuticals consolidated net profit declines 85.86% in the March 2022 quarter
 ( Results - Announcements 02-May-22   16:33 )
  Alembic Pharma receives PAS approval for its sANDA Pregabalin Capsules
 ( Corporate News - 22-Dec-22   13:53 )
  Alembic Pharmaceuticals fixes record date for interim dividend
 ( Market Beat - Reports 27-Jul-22   14:22 )
  Alembic Pharmaceuticals gets USFDA approval
 ( Corporate News - 27-Oct-22   11:52 )
  Alembic Pharma gets PAS nod from USFDA for pregabalin capsules
 ( Hot Pursuit - 22-Dec-22   14:57 )
  Alembic Pharmaceuticals receives USFDA approval for Mesalamine ER Capsules
 ( Corporate News - 02-Nov-22   09:40 )
  Alembic Pharmaceuticals to acquire 40% stake in Aleor Dermaceuticals
 ( Corporate News - 29-Mar-22   15:41 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 20-Jul-23   14:30 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top